AZO
AutoZone, Inc.
There isn't enough reported data to score AZO yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
AZO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
AZO's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AZO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $2,715 | -17% |
| Fair | 20x | $3,032 | -6.8% |
| Current | 21x | $3,252 | — |
| Expensive | 23x | $3,547 | +9.1% |
Historical ranges are pointers, not guarantees.
AZO's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
AZO Forward outlook
There aren't enough analyst estimates for AZO to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AZO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $152.55 | +5.3% |
| Q2 2026 | $145.44 | -1.5% |
| Q1 2026 | $142.73 | -4.2% |
| Q4 2025 | $143.39 | -4.1% |
| Q3 2025 | $144.87 | -3.1% |
| Q2 2025 | $147.59 | +2.3% |
| Q1 2025 | $148.92 | +5.1% |
| Q4 2024 | $149.52 | +8.8% |
AZO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
AZO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +8.4% |
| Q1 2026 | $4.3B | +8.1% |
| Q4 2025 | $4.6B | +8.2% |
| Q2 2025 | $4.5B | +5.4% |
| Q1 2025 | $4B | +2.4% |
| Q4 2024 | $4.3B | +2.1% |
| Q3 2024 | $6.2B | +9% |
| Q2 2024 | $4.2B | +3.5% |
AZO has the stronger quarterly revenue trend. Revenue is up 22% for AZO versus up 4.1% for LCID.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 19% | -0.3 points |
| Q1 2026 | 16% | -1.5 points |
| Q4 2025 | 17% | -2.7 points |
| Q2 2025 | 19% | -1.9 points |
| Q1 2025 | 18% | -1.4 points |
| Q4 2024 | 20% | -0.6 points |
| Q3 2024 | 21% | -0.6 points |
| Q2 2024 | 21% | +0.3 points |
AZO's operating margin was 19% last quarter, up 1.2 points from the same quarter a year ago.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
AZO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $456.5M | +7.9% |
| Q1 2026 | $35.6M | -88% |
| Q4 2025 | $630M | +12% |
| Q2 2025 | $423.1M | -2.6% |
| Q1 2025 | $291M | +63% |
| Q4 2024 | $564.8M | -5.1% |
| Q2 2024 | $434.4M | -22% |
| Q1 2024 | $178.7M | -15% |
AZO's free cash flow has been positive every quarter since late 2019: $1.5B over the past year, up 5.2% from the year before.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
AZO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +13K shares |
| 1 year | -2.2% | -380K shares |
| 3 years | -12% | -2.2M shares |
| 5 years | -26% | -5.9M shares |
| Available history | -31% | -7.6M shares |
AZO has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $580.7M |
| Q1 2026 | $314.5M |
| Q4 2025 | $427.2M |
| Q2 2025 | $268.8M |
| Q1 2025 | $326.4M |
| Q4 2024 | $540.1M |
| Q2 2024 | $728.1M |
| Q1 2024 | $222.2M |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
AZO Net Leverage
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AZO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 80.2 | Overbought |
AZO's weekly RSI is 56 (neutral) and its Stochastic is 80 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
AZO PE vs Consumer Cyclical Sector
| Metric | AZO | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 18% above |
| PE % | 69 | 47 | 22 pts above |
AZO is trading at 21x earnings, a 18% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
AZO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3,070.5 | 5.9% above |
| 20 week MA | $3,030.2 | 7.3% above |
| 50 week MA | $3,287.4 | 1.1% below |
| 100 week MA | $3,508.3 | 7.3% below |
| 200 week MA | $3,135.5 | 3.7% above |
AZO has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
AZO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,202.6 | $1,204.2 | +0.1% |
| 2021 | $1,204.2 | $2,014.5 | +67% |
| 2022 | $2,014.5 | $2,430.7 | +21% |
| 2023 | $2,430.7 | $2,585.6 | +6.4% |
| 2024 | $2,585.6 | $3,241.6 | +25% |
| 2025 | $3,241.6 | $3,448.7 | +6.4% |
| 2026 YTD | $3,448.7 | $3,252.2 | -5.7% |
AZO has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.